{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:02:20Z","timestamp":1780549340282,"version":"3.54.1"},"publisher-location":"Berlin, Heidelberg","reference-count":157,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_304","type":"book-chapter","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:55:59Z","timestamp":1751540159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["EBV and Autoimmunity"],"prefix":"10.1007","author":[{"given":"Marianna","family":"Cortese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ascherio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjetil","family":"Bjornevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"304_CR1","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/jnnp-2020-322941","volume":"91","author":"S Abrahamyan","year":"2020","unstructured":"Abrahamyan S, Eberspacher B, Hoshi MM, Aly L, Luessi F, Groppa S, Klotz L, Meuth SG, Schroeder C, Gruter T, Tackenberg B, Paul F, Then-Bergh F, Kumpfel T, Weber F, Stangel M, Bayas A, Wildemann B, Heesen C, Zettl U, Warnke C, Antony G, Hessler N, Wiendl H, Bittner S, Hemmer B, Gold R, Salmen A, Ruprecht K et al (2020) Complete Epstein-Barr virus Seropositivity in a large cohort of patients with early multiple sclerosis. J Neurol Neurosurg Psychiatry 91:681\u2013686","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"304_CR2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102781","volume":"127","author":"A Afrasiabi","year":"2022","unstructured":"Afrasiabi A, Keane JT, Ong LTC, Alinejad-Rokny H, Fewings NL, Booth DR, Parnell GP, Swaminathan S (2022) Genetic and transcriptomic analyses support a switch to lytic phase in Epstein Barr virus infection as an important driver in developing systemic lupus erythematosus. J Autoimmun 127:102781","journal-title":"J Autoimmun"},{"key":"304_CR3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/acr.24892","volume":"75","author":"A Aguirre","year":"2023","unstructured":"Aguirre A, Izadi Z, Trupin L, Barbour KE, Greenlund KJ, Katz P, Lanata C, Criswell L, Dall\u2019era M, Yazdany J (2023) Race, ethnicity, and disparities in the risk of end-organ lupus manifestations following a systemic lupus erythematosus diagnosis in a multiethnic cohort. Arthrit Care Res (Hoboken) 75:34\u201343","journal-title":"Arthrit Care Res (Hoboken)"},{"key":"304_CR4","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/13524585241235825","volume":"30","author":"F Aloisi","year":"2024","unstructured":"Aloisi F, Salvetti M (2024) Ebv infection drives Ms pathology: yes. Mult Scler 30:483\u2013485","journal-title":"Mult Scler"},{"key":"304_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1474-4422(22)00471-9","volume":"22","author":"F Aloisi","year":"2023","unstructured":"Aloisi F, Giovannoni G, Salvetti M (2023) Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy. Lancet Neurol 22:338\u2013349","journal-title":"Lancet Neurol"},{"key":"304_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.wnl.0000316802.35974.34","volume":"71","author":"A Alonso","year":"2008","unstructured":"Alonso A, Hernan MA (2008) Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71:129\u2013135","journal-title":"Neurology"},{"key":"304_CR8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, Mcclain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349:1526\u20131533","journal-title":"N Engl J Med"},{"key":"304_CR9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/gene.2014.23","volume":"15","author":"DL Armstrong","year":"2014","unstructured":"Armstrong DL, Zidovetzki R, Alarcon-Riquelme ME, Tsao BP, Criswell LA, Kimberly RP, Harley JB, Sivils KL, Vyse TJ, Gaffney PM, Langefeld CD, Jacob CO (2014) Gwas identifies novel Sle susceptibility genes and explains the association of the Hla region. Genes Immun 15:347\u2013354","journal-title":"Genes Immun"},{"key":"304_CR10","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1212\/WNL.0b013e3181dabfb5","volume":"74","author":"A Ascherio","year":"2010","unstructured":"Ascherio A, Bar-Or A (2010) Ebv and brain matter(s)? Neurology 74:1092\u20131095","journal-title":"Neurology"},{"key":"304_CR11","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ana.21117","volume":"61","author":"A Ascherio","year":"2007","unstructured":"Ascherio A, Munger KL (2007) Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 61:288\u2013299","journal-title":"Ann Neurol"},{"key":"304_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-0036-1579693","volume":"36","author":"A Ascherio","year":"2016","unstructured":"Ascherio A, Munger KL (2016) Epidemiology of multiple sclerosis: from risk factors to prevention-an update. Semin Neurol 36:103\u2013114","journal-title":"Semin Neurol"},{"key":"304_CR13","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1001\/jama.286.24.3083","volume":"286","author":"A Ascherio","year":"2001","unstructured":"Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hern\u00e1n MA, Olek MJ, Hankinson SE, Hunter DJ (2001) Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. JAMA 286:3083\u20133088","journal-title":"JAMA"},{"key":"304_CR14","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1177\/0961203320940029","volume":"29","author":"D Aygun","year":"2020","unstructured":"Aygun D, Kuskucu MA, Sahin S, Adrovic A, Barut K, Yildiz M, Sharifova S, Midilli K, Cokugras H, Camcioglu Y, Kasapcopur O (2020) Epstein-Barr virus, cytomegalovirus and Bk polyomavirus burden in juvenile systemic lupus erythematosus: correlation with clinical and laboratory indices of disease activity. Lupus 29:1263\u20131269","journal-title":"Lupus"},{"key":"304_CR15","doi-asserted-by":"crossref","first-page":"1307589","DOI":"10.3389\/fimmu.2023.1307589","volume":"14","author":"A Banko","year":"2023","unstructured":"Banko A, Cirkovic A, Miskovic R, Jeremic I, Grk M, Basaric M, Lazarevic I, Raskovic S, Despotovic A, Miljanovic D (2023) Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus. Front Immunol 14:1307589","journal-title":"Front Immunol"},{"key":"304_CR17","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.molmed.2019.11.003","volume":"26","author":"A Bar-Or","year":"2020","unstructured":"Bar-Or A, Pender MP, Khanna R, Steinman L, Hartung HP, Maniar T, Croze E, Aftab BT, Giovannoni G, Joshi MA (2020) Epstein-Barr virus in multiple sclerosis: theory and emerging immunotherapies. Trends Mol Med 26:296\u2013310","journal-title":"Trends Mol Med"},{"key":"304_CR18","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","volume":"2","author":"RP Beasley","year":"1981","unstructured":"Beasley RP, Hwang LY, Lin CC, Chien CS (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2:1129\u20131133","journal-title":"Lancet"},{"key":"304_CR19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cellimm.2005.06.010","volume":"235","author":"BR Berner","year":"2005","unstructured":"Berner BR, Tary-Lehmann M, Yonkers NL, Askari AD, Lehmann PV, Anthony DD (2005) Phenotypic and functional analysis of Ebv-specific memory Cd8 cells in Sle. Cell Immunol 235:29\u201338","journal-title":"Cell Immunol"},{"key":"304_CR20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1001\/jamaneurol.2019.3238","volume":"77","author":"K Bjornevik","year":"2020","unstructured":"Bjornevik K, Munger KL, Cortese M, Barro C, Healy BC, Niebuhr DW, Scher AI, Kuhle J, Ascherio A (2020) Serum Neurofilament light chain levels in patients with presymptomatic multiple sclerosis. JAMA Neurol 77:58\u201364","journal-title":"JAMA Neurol"},{"key":"304_CR21","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","volume":"375","author":"K Bjornevik","year":"2022","unstructured":"Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A (2022) Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 375:296\u2013301","journal-title":"Science"},{"key":"304_CR22","first-page":"160","volume":"19","author":"K Bjornevik","year":"2023","unstructured":"Bjornevik K, Munz C, Cohen JI, Ascherio A (2023) Epstein-Barr virus as a leading cause of multiple sclerosis: mechanisms and implications. Nat Rev Neurol 19:160\u2013171","journal-title":"Nat Rev Neurol"},{"key":"304_CR23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrc797","volume":"2","author":"C Boshoff","year":"2002","unstructured":"Boshoff C, Weiss R (2002) Aids-related malignancies. Nat Rev Cancer 2:373\u2013382","journal-title":"Nat Rev Cancer"},{"issue":"1305\u20131316","key":"304_CR24","first-page":"E6","volume":"50","author":"W Bu","year":"2019","unstructured":"Bu W, Joyce MG, Nguyen H, Banh DV, Aguilar F, Tariq Z, Yap ML, Tsujimura Y, Gillespie RA, Tsybovsky Y, Andrews SF, Narpala SR, Mcdermott AB, Rossmann MG, Yasutomi Y, Nabel GJ, Kanekiyo M, Cohen JI (2019) Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells. Immunity 50(1305\u20131316):E6","journal-title":"Immunity"},{"key":"304_CR25","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/jnnp.2004.048504","volume":"76","author":"D Buljevac","year":"2005","unstructured":"Buljevac D, Van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, Van Doorn PA, Van Der Meche FG, Hintzen RQ (2005) Epstein-Barr virus and disease activity in multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1377\u20131381","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"304_CR26","doi-asserted-by":"crossref","unstructured":"Buonavoglia A, Leone P, Prete M, Solimando AG, Guastadisegno C, Lanave G, Camero M, Martella V, Lo Muzio L, Racanelli V (2021) Epstein-Barr virus in salivary samples from systemic lupus erythematosus patients with oral lesions. J Clin Med 10","DOI":"10.3390\/jcm10214995"},{"key":"304_CR27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tjog.2024.01.008","volume":"63","author":"CJ Chen","year":"2024","unstructured":"Chen CJ (2024) Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus. Taiwan J Obstet Gynecol 63:161\u2013164","journal-title":"Taiwan J Obstet Gynecol"},{"key":"304_CR28","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s10067-024-06917-4","volume":"43","author":"M Chen","year":"2024","unstructured":"Chen M, Tu J, Huang M, Cheng Y, Sun L (2024) A retrospective cohort study of Epstein-Barr virus infection status and systemic lupus erythematosus. Clin Rheumatol 43:1521\u20131530","journal-title":"Clin Rheumatol"},{"key":"304_CR29","doi-asserted-by":"crossref","first-page":"E32","DOI":"10.1038\/cti.2014.27","volume":"4","author":"JI Cohen","year":"2015","unstructured":"Cohen JI (2015) Epstein-Barr virus vaccines. Clin Transl Immunol 4:E32","journal-title":"Clin Transl Immunol"},{"key":"304_CR30","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0895-4356(02)00429-8","volume":"55","author":"GS Cooper","year":"2002","unstructured":"Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS (2002) Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol 55:982\u2013989","journal-title":"J Clin Epidemiol"},{"key":"304_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/13524585241235837","volume":"30","author":"M Cortese","year":"2024","unstructured":"Cortese M, Ascherio A (2024) Ebv infection drives Ms pathology: commentary. Mult Scler 30:487\u2013488","journal-title":"Mult Scler"},{"key":"304_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/08916930500285758","volume":"38","author":"KH Costenbader","year":"2005","unstructured":"Costenbader KH, Karlson EW (2005) Cigarette smoking and systemic lupus erythematosus: a smoking gun? Autoimmunity 38:541\u2013547","journal-title":"Autoimmunity"},{"key":"304_CR33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/ar1893","volume":"8","author":"KH Costenbader","year":"2006","unstructured":"Costenbader KH, Karlson EW (2006) Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther 8:204","journal-title":"Arthritis Res Ther"},{"key":"304_CR34","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.3389\/fimmu.2019.02619","volume":"10","author":"K Csorba","year":"2019","unstructured":"Csorba K, Schirmbeck LA, Tuncer E, Ribi C, Roux-Lombard P, Chizzolini C, Huynh-Do U, Vanhecke D, Trendelenburg M (2019) Anti-C1q antibodies as occurring in systemic lupus erythematosus could be induced by an Epstein-Barr virus-derived antigenic site. Front Immunol 10:2619","journal-title":"Front Immunol"},{"key":"304_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2014.09.014","volume":"195","author":"L Cuomo","year":"2015","unstructured":"Cuomo L, Cirone M, Di Gregorio AO, Vitillo M, Cattivelli M, Magliocca V, Maiorano S, Meledandri M, Scagnolari C, La Rocca S, Trivedi P (2015) Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses. Virus Res 195:95\u201399","journal-title":"Virus Res"},{"key":"304_CR36","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/09612033221100156","volume":"31","author":"P Das","year":"2022","unstructured":"Das P, Minz RW, Saikia B, Sharma A, Anand S, Singh H, Singh S (2022) Association of human leucocyte antigen class ii, with viral load and immune response to Epstein-Barr virus in adult and pediatric systemic lupus erythematosus patients. Lupus 31:1054\u20131066","journal-title":"Lupus"},{"key":"304_CR37","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJM200108023450506","volume":"345","author":"A Davidson","year":"2001","unstructured":"Davidson A, Diamond B (2001) Autoimmune diseases. N Engl J Med 345:340\u2013350","journal-title":"N Engl J Med"},{"key":"304_CR38","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL De Jager","year":"2008","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A (2008) Integrating risk factors: Hla-Drb1*1501 and Epstein-Barr virus in multiple sclerosis. Neurology 70:1113\u20131118","journal-title":"Neurology"},{"key":"304_CR39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1001\/archneur.63.6.noc50328","volume":"63","author":"GN Delorenze","year":"2006","unstructured":"Delorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006) Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch Neurol 63:839\u2013844","journal-title":"Arch Neurol"},{"key":"304_CR40","doi-asserted-by":"crossref","unstructured":"Demirkaya E, Sahin S, Romano M, Zhou Q, Aksentijevich I (2020) New horizons in the genetic etiology of systemic lupus erythematosus and lupus-like disease: monogenic lupus and beyond. J Clin Med 9","DOI":"10.3390\/jcm9030712"},{"key":"304_CR41","doi-asserted-by":"crossref","first-page":"E318","DOI":"10.1212\/NXI.0000000000000318","volume":"4","author":"R Dobson","year":"2017","unstructured":"Dobson R, Kuhle J, Middeldorp J, Giovannoni G (2017) Epstein-Barr-negative Ms: a true phenomenon? Neurol Neuroimmunol Neuroinflamm 4:E318","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"304_CR42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2016.08.016","volume":"299","author":"MM Dooley","year":"2016","unstructured":"Dooley MM, De Gannes SL, Fu KA, Lindsey JW (2016) The increased antibody response to Epstein-Barr virus in multiple sclerosis is restricted to selected virus proteins. J Neuroimmunol 299:147\u2013151","journal-title":"J Neuroimmunol"},{"key":"304_CR43","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3109\/03009742.2012.665944","volume":"41","author":"AH Draborg","year":"2012","unstructured":"Draborg AH, Jorgensen JM, Muller H, Nielsen CT, Jacobsen S, Iversen LV, Theander E, Nielsen LP, Houen G, Duus K (2012) Epstein-Barr virus early antigen diffuse (Ebv-Ea\/D)-directed immunoglobulin a antibodies in systemic lupus erythematosus patients. Scand J Rheumatol 41:280\u2013289","journal-title":"Scand J Rheumatol"},{"key":"304_CR44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0272-6386(98)70140-4","volume":"32","author":"Y Dror","year":"1998","unstructured":"Dror Y, Blachar Y, Cohen P, Livni N, Rosenmann E, Ashkenazi A (1998) Systemic lupus erythematosus associated with acute Epstein-Barr virus infection. Am J Kidney Dis 32:825\u2013828","journal-title":"Am J Kidney Dis"},{"key":"304_CR45","doi-asserted-by":"crossref","first-page":"12368","DOI":"10.1073\/pnas.2002392117","volume":"117","author":"NC Drosu","year":"2020","unstructured":"Drosu NC, Edelman ER, Housman DE (2020) Tenofovir prodrugs potently inhibit Epstein-Barr virus lytic Dna replication by targeting the viral Dna polymerase. Proc Natl Acad Sci USA 117:12368\u201312374","journal-title":"Proc Natl Acad Sci USA"},{"key":"304_CR46","doi-asserted-by":"crossref","first-page":"E2416097121","DOI":"10.1073\/pnas.2416097121","volume":"121","author":"N Drosu","year":"2024","unstructured":"Drosu N, Anderson M, Bilodeau PA, Nishiyama S, Mikami T, Bobrowski-Khoury N, Cabot J, Housman D, Levy M (2024a) Cd4 T cells restricted to Drb1*15:01 recognize two Epstein-Barr virus glycoproteins capable of intracellular antigen presentation. Proc Natl Acad Sci USA 121:E2416097121","journal-title":"Proc Natl Acad Sci USA"},{"key":"304_CR47","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105444","volume":"82","author":"N Drosu","year":"2024","unstructured":"Drosu N, Bjornevik K, Bilodeau PA, Yeh A, Lechner-Scott J, Hawkes CH, Giovannoni G, Levy M (2024b) In the era of antiviral trials for Ms, the answer lies in the details. Mult Scler Relat Disord 82:105444","journal-title":"Mult Scler Relat Disord"},{"key":"304_CR48","doi-asserted-by":"crossref","unstructured":"Drosu N, Bjornevik K, Cortese M, Levy M, Sollid LM (2024c) Coeliac disease as a model for understanding multiple sclerosis. Nat Rev Neurol","DOI":"10.1038\/s41582-024-01025-y"},{"key":"304_CR49","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1136\/annrheumdis-2022-222276","volume":"81","author":"A Duarte-Garcia","year":"2022","unstructured":"Duarte-Garcia A, Hocaoglu M, Valenzuela-Almada M, Osei-Onomah SA, Dabit JY, Sanchez-Rodriguez A, Duong SQ, Giblon RE, Langenfeld HE, Alarcon GS, Helmick CG, Crowson CS (2022) Rising incidence and prevalence of systemic lupus erythematosus: a population-based study over four decades. Ann Rheum Dis 81:1260\u20131266","journal-title":"Ann Rheum Dis"},{"key":"304_CR50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(71)91937-4","volume":"1","author":"AS Evans","year":"1971","unstructured":"Evans AS, Rothfield NF, Niederman JC (1971) Raised antibody Titres to E.B. Virus in systemic lupus erythematosus. Lancet 1:167\u2013168","journal-title":"Lancet"},{"key":"304_CR51","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.26890","volume":"95","author":"G Fadda","year":"2024","unstructured":"Fadda G, Yea C, O\u2019mahony J, Waters P, Yeh EA, Marrie RA, Arnold D, Bar-Or A, Banwell B et al (2024) Epstein-Barr virus strongly associates with pediatric multiple sclerosis, but not myelin oligodendrocyte glycoprotein-antibody-associated disease. Ann Neurol 95:700\u2013705","journal-title":"Ann Neurol"},{"key":"304_CR52","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.autrev.2007.02.013","volume":"7","author":"G Ferraccioli","year":"2007","unstructured":"Ferraccioli G, Tolusso B (2007) Infections, B cell receptor activation and autoimmunity: different check-point impairments lead to autoimmunity, clonal B cell expansion and fibrosis in different immunological settings. Autoimmun Rev 7:109\u2013113","journal-title":"Autoimmun Rev"},{"key":"304_CR53","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.2414848","volume":"230","author":"RS Fujinami","year":"1985","unstructured":"Fujinami RS, Oldstone MB (1985) Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 230:1043\u20131045","journal-title":"Science"},{"key":"304_CR54","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0301-0082(95)80008-V","volume":"47","author":"CR Gale","year":"1995","unstructured":"Gale CR, Martyn CN (1995) Migrant studies in multiple sclerosis. Prog Neurobiol 47:425\u2013448","journal-title":"Prog Neurobiol"},{"key":"304_CR55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/46218","volume":"402","author":"AW Goldrath","year":"1999","unstructured":"Goldrath AW, Bevan MJ (1999) Selecting and maintaining a diverse T-cell repertoire. Nature 402:255\u2013262","journal-title":"Nature"},{"key":"304_CR56","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.4049\/jimmunol.174.11.6599","volume":"174","author":"AJ Gross","year":"2005","unstructured":"Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA (2005) Ebv and systemic lupus erythematosus: a new perspective. J Immunol 174:6599\u20136607","journal-title":"J Immunol"},{"key":"304_CR57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/ane.12428","volume":"132","author":"N Grytten","year":"2015","unstructured":"Grytten N, Torkildsen O, Myhr KM (2015) Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades. Acta Neurol Scand 132:29\u201336","journal-title":"Acta Neurol Scand"},{"key":"304_CR58","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1186\/ar4429","volume":"16","author":"P Hanlon","year":"2014","unstructured":"Hanlon P, Avenell A, Aucott L, Vickers MA (2014) Systematic review and meta-analysis of the Sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus. Arthritis Res Ther 16:R3","journal-title":"Arthritis Res Ther"},{"key":"304_CR59","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/1529-0131(199908)42:8<1782::AID-ANR36>3.0.CO;2-X","volume":"42","author":"JB Harley","year":"1999","unstructured":"Harley JB, James JA (1999) Epstein-Barr virus infection may be an environmental risk factor for systemic lupus erythematosus in children and teenagers. Arthritis Rheum 42:1782\u20131783","journal-title":"Arthritis Rheum"},{"key":"304_CR60","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","volume":"50","author":"JB Harley","year":"2018","unstructured":"Harley JB, Chen X, Pujato M, Miller D, Maddox A, Forney C, Magnusen AF, Lynch A, Chetal K, Yukawa M, Barski A, Salomonis N, Kaufman KM, Kottyan LC, Weirauch MT (2018) Transcription factors operate across disease loci, with Ebna2 implicated in autoimmunity. Nat Genet 50:699\u2013707","journal-title":"Nat Genet"},{"key":"304_CR61","doi-asserted-by":"crossref","first-page":"E1005414","DOI":"10.1371\/journal.ppat.1005414","volume":"12","author":"MR Harter","year":"2016","unstructured":"Harter MR, Liu CD, Shen CL, Gonzalez-Hurtado E, Zhang ZM, Xu M, Martinez E, Peng CW, Song J (2016) Bs69\/Zmynd11 C-terminal domains bind and inhibit Ebna2. PLoS Pathog 12:E1005414","journal-title":"PLoS Pathog"},{"key":"304_CR62","doi-asserted-by":"crossref","first-page":"E0192109","DOI":"10.1371\/journal.pone.0192109","volume":"13","author":"A Hassani","year":"2018","unstructured":"Hassani A, Corboy JR, Al-Salam S, Khan G (2018) Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells. PLoS One 13:E0192109","journal-title":"PLoS One"},{"key":"304_CR63","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","volume":"376","author":"SL Hauser","year":"2017","unstructured":"Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L, Opera I, Investigators OIC (2017) Ocrelizumab versus interferon Beta-1a in relapsing multiple sclerosis. N Engl J Med 376:221\u2013234","journal-title":"N Engl J Med"},{"key":"304_CR64","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","volume":"11","author":"SM Hayter","year":"2012","unstructured":"Hayter SM, Cook MC (2012) Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev 11:754\u2013765","journal-title":"Autoimmun Rev"},{"key":"304_CR65","doi-asserted-by":"crossref","unstructured":"Hudson E, Yang L, Chu EK, Zhuang H, Arja RD, Betancourt BY, Bhattacharyya I, Han S, Cha S, Chan EKL, Sebastian M, Stalvey C, Fritzler MJ, Reeves WH (2024) Evidence that autoantibody production may be driven by acute Epstein-Barr virus infection in Sjogren\u2019s disease. Ann Rheum Dis","DOI":"10.1136\/ard-2024-226226"},{"key":"304_CR66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.29698","volume":"138","author":"KF Hui","year":"2016","unstructured":"Hui KF, Cheung AK, Choi CK, Yeung PL, Middeldorp JM, Lung ML, Tsao SW, Chiang AK (2016) Inhibition of class I histone deacetylases by Romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir. Int J Cancer 138:125\u2013136","journal-title":"Int J Cancer"},{"key":"304_CR67","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/art.41632","volume":"73","author":"PM Izmirly","year":"2021","unstructured":"Izmirly PM, Parton H, Wang L, Mccune WJ, Lim SS, Drenkard C, Ferucci ED, Dall\u2019era M, Gordon C, Helmick CG, Somers EC (2021) Prevalence of systemic lupus erythematosus in the United States: estimates from a meta-analysis of the centers for disease control and prevention National Lupus Registries. Arthritis Rheumatol 73:991\u2013996","journal-title":"Arthritis Rheumatol"},{"key":"304_CR68","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1352458520907901","volume":"26","author":"BM Jacobs","year":"2020","unstructured":"Jacobs BM, Giovannoni G, Cuzick J, Dobson R (2020) Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler 26:1281\u20131297","journal-title":"Mult Scler"},{"key":"304_CR69","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1365-2249.1994.tb05507.x","volume":"98","author":"JA James","year":"1994","unstructured":"James JA, Mamula MJ, Harley JB (1994) Sequential autoantigenic determinants of the small nuclear ribonucleoprotein Sm D shared by human lupus autoantibodies and Mrl Lpr\/Lpr antibodies. Clin Exp Immunol 98:419\u2013426","journal-title":"Clin Exp Immunol"},{"key":"304_CR70","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","volume":"100","author":"JA James","year":"1997","unstructured":"James JA, Kaufman KM, Farris AD, Taylor-Albert E, Lehman TJ, Harley JB (1997) An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus. J Clin Invest 100:3019\u20133026","journal-title":"J Clin Invest"},{"key":"304_CR71","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00415-016-8360-4","volume":"264","author":"S Jarius","year":"2017","unstructured":"Jarius S, Eichhorn P, Franciotta D, Petereit HF, Akman-Demir G, Wick M, Wildemann B (2017) The Mrz reaction as a highly specific marker of multiple sclerosis: re-evaluation and structured review of the literature. J Neurol 264:453\u2013466","journal-title":"J Neurol"},{"key":"304_CR72","volume":"11","author":"NR Jog","year":"2020","unstructured":"Jog NR, James JA (2020) Epstein Barr virus and autoimmune responses in systemic lupus erythematosus. Front Immunol 11:623944","journal-title":"Front Immunol"},{"key":"304_CR73","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","volume":"78","author":"NR Jog","year":"2019","unstructured":"Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, Kamen DL, Gilkeson GS, Weisman MH, Karp DR, Gaffney PM, Harley JB, Wallace DJ, Norris JM, James JA (2019) Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis 78:1235\u20131241","journal-title":"Ann Rheum Dis"},{"key":"304_CR74","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","volume":"162","author":"M Kanekiyo","year":"2015","unstructured":"Kanekiyo M, Bu W, Joyce MG, Meng G, Whittle JR, Baxa U, Yamamoto T, Narpala S, Todd JP, Rao SS, Mcdermott AB, Koup RA, Rossmann MG, Mascola JR, Graham BS, Cohen JI, Nabel GJ (2015) Rational design of an Epstein-Barr virus vaccine targeting the receptor-binding site. Cell 162:1090\u20131100","journal-title":"Cell"},{"key":"304_CR75","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","volume":"172","author":"I Kang","year":"2004","unstructured":"Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J (2004) Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol 172:1287\u20131294","journal-title":"J Immunol"},{"key":"304_CR76","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1749-6632.2003.tb06051.x","volume":"987","author":"KM Kaufman","year":"2003","unstructured":"Kaufman KM, Kirby MY, Harley JB, James JA (2003) Peptide mimics of a major lupus epitope of Smb\/B. Ann N Y Acad Sci 987:215\u2013229","journal-title":"Ann N Y Acad Sci"},{"key":"304_CR77","doi-asserted-by":"crossref","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","volume":"2","author":"A Kaul","year":"2016","unstructured":"Kaul A, Gordon C, Crow MK, Touma Z, Urowitz MB, Van Vollenhoven R, Ruiz-Irastorza G, Hughes G (2016) Systemic lupus erythematosus. Nat Rev Dis Primers 2:16039","journal-title":"Nat Rev Dis Primers"},{"key":"304_CR78","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1212\/WNL.35.9.1381","volume":"35","author":"LS Klavinskis","year":"1985","unstructured":"Klavinskis LS, Willcox N, Oxford JS, Newsom-Davis J (1985) Antivirus antibodies in myasthenia gravis. Neurology 35:1381\u20131384","journal-title":"Neurology"},{"key":"304_CR79","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(73)92662-7","volume":"2","author":"JH Klippel","year":"1973","unstructured":"Klippel JH, Decker JL (1973) Epstein-Barr virus antibody and lymphocyte tubuloreticular structures in systemic lupus erythematosus. Lancet 2:1057\u20131058","journal-title":"Lancet"},{"key":"304_CR80","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S1474-4422(10)70064-8","volume":"9","author":"N Koch-Henriksen","year":"2010","unstructured":"Koch-Henriksen N, Sorensen PS (2010) The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol 9:520\u2013532","journal-title":"Lancet Neurol"},{"key":"304_CR81","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41582-023-00800-7","volume":"19","author":"J Kramer","year":"2023","unstructured":"Kramer J, Bar-Or A, Turner TJ, Wiendl H (2023) Bruton tyrosine kinase inhibitors for multiple sclerosis. Nat Rev Neurol 19:289\u2013304","journal-title":"Nat Rev Neurol"},{"key":"304_CR82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0895-4356(00)00268-7","volume":"54","author":"JF Kurtzke","year":"2001","unstructured":"Kurtzke JF, Heltberg A (2001) Multiple sclerosis in The Faroe Islands: an epitome. J Clin Epidemiol 54:1\u201322","journal-title":"J Clin Epidemiol"},{"key":"304_CR83","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk LL, Thorley-Lawson DA (2005) Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 79:1296\u20131307","journal-title":"J Virol"},{"key":"304_CR84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1615\/CritRevImmunol.v37.i2-6.100","volume":"37","author":"JD Laman","year":"2017","unstructured":"Laman JD, Claassen E, Noelle RJ (2017) Functions of Cd40 and its ligand, Gp39 (Cd40l). Crit Rev Immunol 37:371\u2013420","journal-title":"Crit Rev Immunol"},{"key":"304_CR85","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41586-022-04432-7","volume":"603","author":"TV Lanz","year":"2022","unstructured":"Lanz TV, Brewer RC, Ho PP, Moon JS, Jude KM, Fernandez D, Fernandes RA, Gomez AM, Nadj GS, Bartley CM, Schubert RD, Hawes IA, Vazquez SE, Iyer M, Zuchero JB, Teegen B, Dunn JE, Lock CB, Kipp LB, Cotham VC, Ueberheide BM, Aftab BT, Anderson MS, Derisi JL, Wilson MR, Bashford-Rogers RJM, Platten M, Garcia KC, Steinman L, Robinson WH (2022) Clonally expanded B cells in multiple sclerosis bind Ebv Ebna1 and Glialcam. Nature 603:321\u2013327","journal-title":"Nature"},{"key":"304_CR86","doi-asserted-by":"crossref","first-page":"E1002328","DOI":"10.1371\/journal.ppat.1002328","volume":"7","author":"M Larsen","year":"2011","unstructured":"Larsen M, Sauce D, Deback C, Arnaud L, Mathian A, Miyara M, Boutolleau D, Parizot C, Dorgham K, Papagno L, Appay V, Amoura Z, Gorochov G (2011) Exhausted cytotoxic control of Epstein-Barr virus in human lupus. PLoS Pathog 7:E1002328","journal-title":"PLoS Pathog"},{"key":"304_CR87","doi-asserted-by":"crossref","unstructured":"Laurynenka V, Harley JB (2024) The 330 risk loci known for systemic lupus erythematosus (Sle): a review. Front Lupus 2","DOI":"10.3389\/flupu.2024.1398035"},{"key":"304_CR88","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.830993","volume":"13","author":"V Laurynenka","year":"2022","unstructured":"Laurynenka V, Ding L, Kaufman KM, James JA, Harley JB (2022) A high prevalence of anti-Ebna1 heteroantibodies in systemic lupus erythematosus (Sle) supports anti-Ebna1 as an origin for Sle autoantibodies. Front Immunol 13:830993","journal-title":"Front Immunol"},{"key":"304_CR89","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","volume":"19","author":"ZX Li","year":"2019","unstructured":"Li ZX, Zeng S, Wu HX, Zhou Y (2019) The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med 19:23\u201336","journal-title":"Clin Exp Med"},{"key":"304_CR90","doi-asserted-by":"crossref","unstructured":"Li V, Mckay FC, Tscharke DC, Smith C, Khanna R, Lechner-Scott J, Rawlinson WD, Lloyd AR, Taylor BV, Morahan JM, Steinman L, Giovannoni G, Bar-Or A, Levy M, Drosu N, Potter A, Caswell N, Smith L, Brady EC, Frost B, Hodgkinson S, Hardy TA, Broadley SA et al (2025) Repurposing licensed drugs with activity against Epstein-Barr virus for treatment of multiple sclerosis: a systematic approach. CNS Drugs","DOI":"10.1007\/s40263-024-01153-5"},{"key":"304_CR91","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1352458508097920","volume":"15","author":"J Lindsey","year":"2009","unstructured":"Lindsey J, Hatfield L, Crawford M, Patel S (2009) Quantitative Pcr for Epstein-Barr virus Dna and Rna in multiple sclerosis. Mult Scler 15:153\u2013158","journal-title":"Mult Scler"},{"key":"304_CR92","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1172\/JCI1528","volume":"101","author":"AE Lovett-Racke","year":"1998","unstructured":"Lovett-Racke AE, Trotter JL, Lauber J, Perrin PJ, June CH, Racke MK (1998) Decreased dependence of myelin basic protein-reactive T cells on Cd28-mediated Costimulation in multiple sclerosis patients. A marker of activated\/memory T cells. J Clin Invest 101:725\u2013730","journal-title":"J Clin Invest"},{"key":"304_CR93","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"C Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H (2000) Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47:707\u2013717","journal-title":"Ann Neurol"},{"key":"304_CR94","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen A, Muller F, Mougiakakos D, Boltz S, Wilhelm A, Aigner M, Volkl S, Simon D, Kleyer A, Munoz L, Kretschmann S, Kharboutli S, Gary R, Reimann H, Rosler W, Uderhardt S, Bang H, Herrmann M, Ekici AB, Buettner C, Habenicht KM, Winkler TH, Kronke G, Schett G (2022) Anti-Cd19 car T cell therapy for refractory systemic lupus erythematosus. Nat Med 28:2124\u20132132","journal-title":"Nat Med"},{"key":"304_CR95","volume-title":"Epidemiology: principles and methods","author":"B Macmahon","year":"1996","unstructured":"Macmahon B, Trichopolous D (1996) Epidemiology: principles and methods. Little, Brown, & Co., Boston"},{"key":"304_CR96","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/acr.23887","volume":"72","author":"E Maningding","year":"2020","unstructured":"Maningding E, Dall\u2019era M, Trupin L, Murphy LB, Yazdany J (2020) Racial and ethnic differences in the prevalence and time to onset of manifestations of systemic lupus erythematosus: the California lupus surveillance project. Arthritis Care Res (Hoboken) 72:622\u2013629","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"304_CR97","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(11)61171-9","volume":"379","author":"E Marijon","year":"2012","unstructured":"Marijon E, Mirabel M, Celermajer DS, Jouven X (2012) Rheumatic heart disease. Lancet 379:953\u2013964","journal-title":"Lancet"},{"key":"304_CR98","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI200112516","volume":"108","author":"S Markovic-Plese","year":"2001","unstructured":"Markovic-Plese S, Cortese I, Wandinger KP, Mcfarland HF, Martin R (2001) Cd4+Cd28- Costimulation-independent T cells in multiple sclerosis. J Clin Invest 108:1185\u20131194","journal-title":"J Clin Invest"},{"key":"304_CR99","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nm1167","volume":"11","author":"MT Mcclain","year":"2005","unstructured":"Mcclain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA (2005) Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nat Med 11:85\u201389","journal-title":"Nat Med"},{"key":"304_CR100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ana.26840","volume":"95","author":"KA Mckay","year":"2024","unstructured":"Mckay KA, Wijnands JMA, Manouchehrinia A, Zhu F, Sereda P, Li J, Ye M, Trigg J, Kooij K, Ekstrom AM, Gisslen M, Hillert J, Hogg RS, Tremlett H, Kingwell E (2024) Risk of multiple sclerosis in people living with Hiv: an international cohort study. Ann Neurol 95:487\u2013494","journal-title":"Ann Neurol"},{"key":"304_CR101","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1212\/WNL.0000000000001420","volume":"84","author":"R Mechelli","year":"2015","unstructured":"Mechelli R, Manzari C, Policano C, Annese A, Picardi E, Umeton R, Fornasiero A, D\u2019erchia AM, Buscarinu MC, Agliardi C, Annibali V, Serafini B, Rosicarelli B, Romano S, Angelini DF, Ricigliano VA, Buttari F, Battistini L, Centonze D, Guerini FR, D\u2019alfonso S, Pesole G, Salvetti M, Ristori G (2015) Epstein-Barr virus genetic variants are associated with multiple sclerosis. Neurology 84:1362\u20131368","journal-title":"Neurology"},{"key":"304_CR102","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10067-022-06369-8","volume":"42","author":"B Ming","year":"2023","unstructured":"Ming B, Bai M, Cai S, Wang B, Zhong J, Dong L (2023) Clinical characteristics of Sle patients infected with Epstein-Barr virus and potential associated risk factors. Clin Rheumatol 42:101\u2013109","journal-title":"Clin Rheumatol"},{"key":"304_CR103","doi-asserted-by":"crossref","first-page":"R295","DOI":"10.1186\/ar1181","volume":"6","author":"UY Moon","year":"2004","unstructured":"Moon UY, Park SJ, Oh ST, Kim WU, Park SH, Lee SH, Cho CS, Kim HY, Lee WK, Lee SK (2004) Patients with systemic lupus erythematosus have abnormally elevated Epstein-Barr virus load in blood. Arthritis Res Ther 6:R295\u2013R302","journal-title":"Arthritis Res Ther"},{"key":"304_CR104","doi-asserted-by":"crossref","first-page":"E466","DOI":"10.1212\/NXI.0000000000000466","volume":"5","author":"MA Moreno","year":"2018","unstructured":"Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH (2018) Molecular signature of Epstein-Barr virus infection in Ms brain lesions. Neurol Neuroimmunol Neuroinflamm 5:E466","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6071\u20136087","key":"304_CR105","first-page":"E20","volume":"187","author":"S Mori","year":"2024","unstructured":"Mori S, Kohyama M, Yasumizu Y, Tada A, Tanzawa K, Shishido T, Kishida K, Jin H, Nishide M, Kawada S, Motooka D, Okuzaki D, Naito R, Nakai W, Kanda T, Murata T, Terao C, Ohmura K, Arase N, Kurosaki T, Fujimoto M, Suenaga T, Kumanogoh A, Sakaguchi S, Ogawa Y, Arase H (2024) Neoself-antigens are the primary target for autoreactive T cells in human lupus. Cell 187(6071\u20136087):E20","journal-title":"Cell"},{"key":"304_CR106","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","volume":"390","author":"F Muller","year":"2024","unstructured":"Muller F, Taubmann J, Bucci L, Wilhelm A, Bergmann C, Volkl S, Aigner M, Rothe T, Minopoulou I, Tur C, Knitza J, Kharboutli S, Kretschmann S, Vasova I, Spoerl S, Reimann H, Munoz L, Gerlach RG, Schafer S, Grieshaber-Bouyer R, Korganow AS, Farge-Bancel D, Mougiakakos D, Bozec A, Winkler T, Kronke G, Mackensen A, Schett G (2024) Cd19 car T-cell therapy in autoimmune disease \u2013 a case series with follow-up. N Engl J Med 390:687\u2013700","journal-title":"N Engl J Med"},{"key":"304_CR107","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1177\/1352458511408991","volume":"17","author":"KL Munger","year":"2011","unstructured":"Munger KL, Levin LI, O\u2019reilly EJ, Falk KI, Ascherio A (2011) Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel. Mult Scler 17:1185\u20131193","journal-title":"Mult Scler"},{"key":"304_CR108","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1212\/WNL.0000000000002099","volume":"85","author":"KL Munger","year":"2015","unstructured":"Munger KL, Fitzgerald KC, Freedman MS, Hartung HP, Miller DH, Montalban X, Edan G, Barkhof F, Suarez G, Radue EW, Sandbrink R, Kappos L, Pohl C, Ascherio A (2015) No association of multiple sclerosis activity and progression with Ebv Or tobacco use in benefit. Neurology 85:1694\u20131701","journal-title":"Neurology"},{"key":"304_CR109","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1093\/brain\/awz088","volume":"142","author":"N Munk Nielsen","year":"2019","unstructured":"Munk Nielsen N, Corn G, Frisch M, Stenager E, Koch-Henriksen N, Wohlfahrt J, Magyari M, Melbye M (2019) Multiple sclerosis among first- and second-generation immigrants in Denmark: a population-based cohort study. Brain 142:1587\u20131597","journal-title":"Brain"},{"key":"304_CR110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/archneur.64.1.72","volume":"64","author":"TR Nielsen","year":"2007","unstructured":"Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Haahr S, Sorensen PS, Hjalgrim H (2007) Multiple sclerosis after infectious mononucleosis. Arch Neurol 64:72\u201375","journal-title":"Arch Neurol"},{"key":"304_CR111","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S1474-4422(06)70581-6","volume":"5","author":"SM Orton","year":"2006","unstructured":"Orton SM, Herrera BM, Yee IM, Valdar W, Ramagopalan SV et al (2006) Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol 5:932\u2013936","journal-title":"Lancet Neurol"},{"key":"304_CR112","doi-asserted-by":"crossref","unstructured":"Otsuka K, Sato M, Tsunematsu T, Ishimaru N (2022) Virus infections play crucial roles in the pathogenesis of Sjogren\u2019s syndrome. Viruses 14","DOI":"10.3390\/v14071474"},{"key":"304_CR113","doi-asserted-by":"crossref","first-page":"E200332","DOI":"10.1212\/NXI.0000000000200332","volume":"12","author":"F Pache","year":"2025","unstructured":"Pache F, Otto C, Wilken D, Lietzow T, Steinhagen K, Grage-Griebenow E, Schindler P, Niederschweiberer M, Wildemann B, Jarius S, Ruprecht K (2025) Broad analysis of serum and intrathecal antimicrobial antibodies in multiple sclerosis underscores unique role of Epstein-Barr virus. Neurol Neuroimmunol Neuroinflamm 12:E200332","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"304_CR114","doi-asserted-by":"crossref","first-page":"E137","DOI":"10.1093\/brain\/awp296","volume":"133","author":"LA Peferoen","year":"2010","unstructured":"Peferoen LA, Lamers F, Lodder LN, Gerritsen WH, Huitinga I, Melief J, Giovannoni G, Meier U, Hintzen RQ, Verjans GM, Van Nierop GP, Vos W, Peferoen-Baert RM, Middeldorp JM, Van Der Valk P, Amor S (2010) Epstein Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis. Brain 133:E137","journal-title":"Brain"},{"key":"304_CR115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.it.2003.09.005","volume":"24","author":"MP Pender","year":"2003","unstructured":"Pender MP (2003) Infection of autoreactive B lymphocytes with Ebv, causing chronic autoimmune diseases. Trends Immunol 24:584\u2013588","journal-title":"Trends Immunol"},{"key":"304_CR116","doi-asserted-by":"crossref","unstructured":"Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R (2020) Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis. JCI Insight 5","DOI":"10.1172\/jci.insight.144624"},{"key":"304_CR117","first-page":"523","volume":"18","author":"A Piroozmand","year":"2017","unstructured":"Piroozmand A, Haddad Kashani H, Zamani B (2017) Correlation between Epstein-Barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev 18:523\u2013527","journal-title":"Asian Pac J Cancer Prev"},{"key":"304_CR118","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/annrheumdis-2018-213783","volume":"77","author":"DS Pisetsky","year":"2018","unstructured":"Pisetsky DS (2018) Role of Epstein-Barr virus infection in Sle: gene-environment interactions at the molecular level. Ann Rheum Dis 77:1249\u20131250","journal-title":"Ann Rheum Dis"},{"key":"304_CR120","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jaut.2008.08.007","volume":"31","author":"BD Poole","year":"2008","unstructured":"Poole BD, Gross T, Maier S, Harley JB, James JA (2008) Lupus-like autoantibody development in rabbits and mice after immunization with Ebna-1 fragments. J Autoimmun 31:362\u2013371","journal-title":"J Autoimmun"},{"key":"304_CR121","doi-asserted-by":"crossref","unstructured":"Quaglia M, Merlotti G, De Andrea M, Borgogna C, Cantaluppi V (2021) Viral infections and systemic lupus erythematosus: new players in an old story. Viruses 13","DOI":"10.3390\/v13020277"},{"key":"304_CR122","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archneurol.2011.48","volume":"68","author":"SV Ramagopalan","year":"2011","unstructured":"Ramagopalan SV, Meier UC, Conacher M, Ebers GC, Giovannoni G, Crawford DH, Mcaulay KA (2011) Role of the Hla system in the association between multiple sclerosis and infectious mononucleosis. Arch Neurol 68:469\u2013472","journal-title":"Arch Neurol"},{"key":"304_CR123","volume":"79","author":"BE Rod","year":"2023","unstructured":"Rod BE, Wergeland S, Bjornevik K, Holmoy T, Ulvestad E, Njolstad G, Myhr KM, Torkildsen O (2023) Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. Mult Scler Relat Disord 79:105037","journal-title":"Mult Scler Relat Disord"},{"key":"304_CR124","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/eji.1830230525","volume":"23","author":"A Sabbatini","year":"1993","unstructured":"Sabbatini A, Bombardieri S, Migliorini P (1993) Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of Smd and Epstein-Barr virus-encoded nuclear antigen Ebna I. Eur J Immunol 23:1146\u20131152","journal-title":"Eur J Immunol"},{"key":"304_CR125","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1212\/WNL.0b013e3181d865a1","volume":"74","author":"SA Sargsyan","year":"2010","unstructured":"Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlohner S, Owens GP, Gilden D, Bennett JL (2010) Absence of Epstein-Barr virus in the brain and Csf of patients with multiple sclerosis. Neurology 74:1127\u20131135","journal-title":"Neurology"},{"key":"304_CR126","doi-asserted-by":"crossref","unstructured":"Schneider-Hohendorf T, Gerdes LA, Pignolet B, Gittelman R, Ostkamp P, Rubelt F, Raposo C, Tackenberg B, Riepenhausen M, Janoschka C, Wunsch C, Bucciarelli F, Flierl-Hecht A, Beltran E, Kumpfel T, Anslinger K, Gross CC, Chapman H, Kaplan I, Brassat D, Wekerle H, Kerschensteiner M, Klotz L, Lunemann JD, Hohlfeld R, Liblau R, Wiendl H, Schwab N (2022) Broader Epstein-Barr virus-specific T cell receptor repertoire in patients with multiple sclerosis. J Exp Med 219","DOI":"10.1084\/jem.20220650"},{"key":"304_CR127","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1084\/jem.20071030","volume":"204","author":"B Serafini","year":"2007","unstructured":"Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007) Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 204:2899\u20132912","journal-title":"J Exp Med"},{"key":"304_CR128","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1742-1241.2007.01434.x","volume":"61","author":"JF Simard","year":"2007","unstructured":"Simard JF, Costenbader KH (2007) What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract 61:1170\u20131180","journal-title":"Int J Clin Pract"},{"key":"304_CR129","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molimm.2021.01.013","volume":"132","author":"D Singh","year":"2021","unstructured":"Singh D, Oudit O, Hajtovic S, Sarbaugh D, Salis R, Adebowale T, James J, Spatz LA (2021a) Antibodies to an Epstein Barr virus protein that cross-react with Dsdna have pathogenic potential. Mol Immunol 132:41\u201352","journal-title":"Mol Immunol"},{"key":"304_CR130","volume":"2","author":"JA Singh","year":"2021","unstructured":"Singh JA, Shah NP, Mudano AS (2021b) Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev 2:Cd010668","journal-title":"Cochrane Database Syst Rev"},{"key":"304_CR131","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, Leonard P, Moreels A, Haumont M, Bollen A, Smets F, Denis M (2007) Recombinant Gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults. J Infect Dis 196:1749\u20131753","journal-title":"J Infect Dis"},{"key":"304_CR132","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41579-022-00770-5","volume":"21","author":"SS Soldan","year":"2023","unstructured":"Soldan SS, Lieberman PM (2023) Epstein-Barr virus and multiple sclerosis. Nat Rev Microbiol 21:51\u201364","journal-title":"Nat Rev Microbiol"},{"key":"304_CR133","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41564-024-01699-6","volume":"9","author":"SS Soldan","year":"2024","unstructured":"Soldan SS, Su C, Monaco MC, Yoon L, Kannan T, Zankharia U, Patel RJ, Dheekollu J, Vladimirova O, Dowling JW, Thebault S, Brown N, Clauze A, Andrada F, Feder A, Planet PJ, Kossenkov A, Schaffer DE, Ohayon J, Auslander N, Jacobson S, Lieberman PM (2024) Multiple sclerosis patient-derived spontaneous B cells have distinct Ebv and host gene expression profiles in active disease. Nat Microbiol 9:1540\u20131554","journal-title":"Nat Microbiol"},{"key":"304_CR134","doi-asserted-by":"crossref","first-page":"Eabo7799","DOI":"10.1126\/sciimmunol.abo7799","volume":"7","author":"LM Sollid","year":"2022","unstructured":"Sollid LM (2022) Epstein-Barr virus as a driver of multiple sclerosis. Sci Immunol 7:Eabo7799","journal-title":"Sci Immunol"},{"key":"304_CR135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/00365513.2018.1550807","volume":"79","author":"L Sternbaek","year":"2019","unstructured":"Sternbaek L, Draborg AH, Osterlund MT, Iversen LV, Troelsen L, Theander E, Nielsen CT, Jacobsen S, Houen G (2019) Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology. Scand J Clin Lab Invest 79:7\u201316","journal-title":"Scand J Clin Lab Invest"},{"key":"304_CR136","doi-asserted-by":"crossref","first-page":"229-56, V-Vi","DOI":"10.1016\/S0889-857X(05)70137-X","volume":"26","author":"KE Sullivan","year":"2000","unstructured":"Sullivan KE (2000) Genetics of systemic lupus erythematosus. Clinical implications. Rheum Dis Clin N Am 26:229-56, V-Vi","journal-title":"Rheum Dis Clin N Am"},{"key":"304_CR137","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/13524585241235833","volume":"30","author":"BA t\u2019 Hart","year":"2024","unstructured":"t\u2019 Hart BA, Van Luijn MM (2024) Ebv infection drives Ms pathology: no. Mult Scler 30:485\u2013487","journal-title":"Mult Scler"},{"key":"304_CR138","doi-asserted-by":"crossref","first-page":"16955","DOI":"10.1073\/pnas.1902623116","volume":"116","author":"K Tengvall","year":"2019","unstructured":"Tengvall K, Huang J, Hellstrom C, Kammer P, Bistrom M, Ayoglu B, Lima Bomfim I, Stridh P, Butt J, Brenner N, Michel A, Lundberg K, Padyukov L, Lundberg IE, Svenungsson E, Ernberg I, Olafsson S, Dilthey AT, Hillert J, Alfredsson L, Sundstrom P, Nilsson P, Waterboer T, Olsson T, Kockum I (2019) Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk. Proc Natl Acad Sci USA 116:16955\u201316960","journal-title":"Proc Natl Acad Sci USA"},{"key":"304_CR139","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.20820","volume":"59","author":"EL Thacker","year":"2006","unstructured":"Thacker EL, Mirzaei F, Ascherio A (2006) Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol 59:499\u2013503","journal-title":"Ann Neurol"},{"key":"304_CR140","volume":"9","author":"OG Thomas","year":"2023","unstructured":"Thomas OG, Bronge M, Tengvall K, Akpinar B, Nilsson OB, Holmgren E, Hessa T, Gafvelin G, Khademi M, Alfredsson L, Martin R, Guerreiro-Cacais AO, Gronlund H, Olsson T, Kockum I (2023) Cross-reactive Ebna1 immunity targets alpha-Crystallin B and is associated with multiple sclerosis. Sci Adv 9:Eadg3032","journal-title":"Sci Adv"},{"key":"304_CR141","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/08916930701510673","volume":"40","author":"L Truedsson","year":"2007","unstructured":"Truedsson L, Bengtsson AA, Sturfelt G (2007) Complement deficiencies and systemic lupus erythematosus. Autoimmunity 40:560\u2013566","journal-title":"Autoimmunity"},{"key":"304_CR142","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121","journal-title":"N Engl J Med"},{"key":"304_CR143","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/rheumatology\/keq148","volume":"49","author":"CJ Ulff-Moller","year":"2010","unstructured":"Ulff-Moller CJ, Nielsen NM, Rostgaard K, Hjalgrim H, Frisch M (2010) Epstein-Barr virus-associated infectious mononucleosis and risk of systemic lupus erythematosus. Rheumatology (Oxford) 49:1706\u20131712","journal-title":"Rheumatology (Oxford)"},{"key":"304_CR144","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1046\/j.1365-2133.2002.04627.x","volume":"146","author":"R Verdolini","year":"2002","unstructured":"Verdolini R, Bugatti L, Giangiacomi M, Nicolini M, Filosa G, Cerio R (2002) Systemic lupus erythematosus induced by Epstein-Barr virus infection. Br J Dermatol 146:877\u2013881","journal-title":"Br J Dermatol"},{"key":"304_CR145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12974-017-1049-5","volume":"15","author":"C Veroni","year":"2018","unstructured":"Veroni C, Serafini B, Rosicarelli B, Fagnani C, Aloisi F (2018) Transcriptional profile and Epstein-Barr virus infection status of laser-cut immune infiltrates from the brain of patients with progressive multiple sclerosis. J Neuroinflammation 15:18","journal-title":"J Neuroinflammation"},{"key":"304_CR146","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1084\/jem.20031579","volume":"199","author":"V Viglietta","year":"2004","unstructured":"Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by Cd4+Cd25+ regulatory T cells in patients with multiple sclerosis. J Exp Med 199:971\u2013979","journal-title":"J Exp Med"},{"key":"304_CR147","doi-asserted-by":"crossref","first-page":"E000214","DOI":"10.1136\/lupus-2017-000214","volume":"4","author":"ES Vista","year":"2017","unstructured":"Vista ES, Weisman MH, Ishimori ML, Chen H, Bourn RL, Bruner BF, Hamijoyo L, Tanangunan RD, Gal NJ, Robertson JM, Harley JB, Guthridge JM, Navarra SV, James JA (2017) Strong viral associations with Sle among Filipinos. Lupus Sci Med 4:E000214","journal-title":"Lupus Sci Med"},{"key":"304_CR148","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1468-1331.2004.00871.x","volume":"11","author":"H-J Wagner","year":"2004","unstructured":"Wagner H-J, Munger KL, Ascherio A (2004) Plasma viral load of Epstein-Barr virus and risk of multiple sclerosis. Eur J Neurol 11:833\u2013834","journal-title":"Eur J Neurol"},{"key":"304_CR149","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1093\/brain\/aws099","volume":"135","author":"MT Wallin","year":"2012","unstructured":"Wallin MT, Culpepper WJ, Coffman P, Pulaski S, Maloni H, Mahan CM, Haselkorn JK, Kurtzke JF et al (2012) The Gulf war era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 135:1778\u20131785","journal-title":"Brain"},{"key":"304_CR150","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, Van Der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P (2020) Rising prevalence of multiple sclerosis worldwide: insights from the atlas of Ms, third edition. Mult Scler 26:1816\u20131821","journal-title":"Mult Scler"},{"key":"304_CR151","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0306-9877(88)90024-2","volume":"25","author":"HB Warner","year":"1988","unstructured":"Warner HB, Carp RI (1988) Multiple sclerosis etiology \u2013 an Epstein-Barrr virus hypothesis. Med Hypotheses 25:93\u201397","journal-title":"Med Hypotheses"},{"key":"304_CR152","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1093\/brain\/awp200","volume":"132","author":"SN Willis","year":"2009","unstructured":"Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Bruck W, Hafler DA, O\u2019connor KC (2009) Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 132:3318\u20133328","journal-title":"Brain"},{"key":"304_CR153","volume":"4","author":"RA Wood","year":"2021","unstructured":"Wood RA, Guthridge L, Thurmond E, Guthridge CJ, Kheir JM, Bourn RL, Wagner CA, Chen H, Dejager W, Macwana SR, Kamp S, Lu R, Arriens C, Chakravarty EF, Thanou A, Merrill JT, Guthridge JM, James JA (2021) Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus. J Transl Autoimmun 4:100117","journal-title":"J Transl Autoimmun"},{"key":"304_CR154","doi-asserted-by":"crossref","first-page":"E14488","DOI":"10.1371\/journal.pone.0014488","volume":"6","author":"P Yadav","year":"2011","unstructured":"Yadav P, Tran H, Ebegbe R, Gottlieb P, Wei H, Lewis RH, Mumbey-Wafula A, Kaplan A, Kholdarova E, Spatz L (2011) Antibodies elicited in response to Ebna-1 may cross-react with Dsdna. PLoS One 6:E14488","journal-title":"PLoS One"},{"key":"304_CR155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/iid3.119","volume":"4","author":"P Yadav","year":"2016","unstructured":"Yadav P, Carr MT, Yu R, Mumbey-Wafula A, Spatz LA (2016) Mapping an epitope in Ebna-1 that is recognized by monoclonal antibodies to Ebna-1 that cross-react with Dsdna. Immun Inflamm Dis 4:362\u2013375","journal-title":"Immun Inflamm Dis"},{"key":"304_CR156","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.0b013e3182a841e4","volume":"81","author":"C Yea","year":"2013","unstructured":"Yea C, Tellier R, Chong P, Westmacott G, Marrie RA, Bar-Or A, Banwell B, On Behalf Of The Canadian Pediatric Demyelinating Disease Network (2013) Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology 81:1392\u20131399","journal-title":"Neurology"},{"key":"304_CR157","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/rheumatology\/keu412","volume":"54","author":"CS Yee","year":"2015","unstructured":"Yee CS, Su L, Toescu V, Hickman R, Situnayake D, Bowman S, Farewell V, Gordon C (2015) Birmingham Sle cohort: outcomes of a large inception cohort followed for up to 21 years. Rheumatology (Oxford) 54:836\u2013843","journal-title":"Rheumatology (Oxford)"},{"key":"304_CR158","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/s41591-024-02938-3","volume":"30","author":"CR Zamecnik","year":"2024","unstructured":"Zamecnik CR, Sowa GM, Abdelhak A, Dandekar R, Bair RD, Wade KJ, Bartley CM, Kizer K, Augusto DG, Tubati A, Gomez R, Fouassier C, Gerungan C, Caspar CM, Alexander J, Wapniarski AE, Loudermilk RP, Eggers EL, Zorn KC, Ananth K, Jabassini N, Mann SA, Ragan NR, Santaniello A, Henry RG, Baranzini SE, Zamvil SS, Sabatino JJ Jr, Bove RM, Guo CY, Gelfand JM, Cuneo R, Von Budingen HC, Oksenberg JR, Cree BAC, Hollenbach JA, Green AJ, Hauser SL, Wallin MT, Derisi JL, Wilson MR (2024) An autoantibody signature predictive for multiple sclerosis. Nat Med 30:1300\u20131308","journal-title":"Nat Med"},{"key":"304_CR159","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1749-6632.2009.04754.x","volume":"1173","author":"G Zandman-Goddard","year":"2009","unstructured":"Zandman-Goddard G, Berkun Y, Barzilai O, Boaz M, Blank M, Ram M, Sherer Y, Anaya JM, Shoenfeld Y (2009) Exposure to Epstein-Barr virus infection is associated with mild systemic lupus erythematosus disease. Ann N Y Acad Sci 1173:658\u2013663","journal-title":"Ann N Y Acad Sci"},{"key":"304_CR160","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/eji.202048655","volume":"51","author":"H Zdimerova","year":"2021","unstructured":"Zdimerova H, Murer A, Engelmann C, Raykova A, Deng Y, Gujer C, Ruhl J, Mchugh D, Caduff N, Naghavian R, Pezzino G, Capaul R, Zbinden A, Ferlazzo G, Lunemann JD, Martin R, Chatterjee B, Munz C (2021) Attenuated immune control of Epstein-Barr virus in humanized mice is associated with the multiple sclerosis risk factor Hla-Dr15. Eur J Immunol 51:64\u201375","journal-title":"Eur J Immunol"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T10:56:21Z","timestamp":1751540181000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_304"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":157,"URL":"https:\/\/doi.org\/10.1007\/82_2025_304","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"4 July 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}